Navellier & Associates Inc
Source: SEC Form 13F · as of Mar 2026Navellier & Associates Inc holds 26 biotech & pharma companies tracked by BioSniper, totaling $74.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$74.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 27,494 | $25.3M |
| CAHCardinal Health Inc. | 66,149 | $14.0M |
| ABBVAbbVie Inc. | 28,305 | $6.2M |
| ARGXARGENX SE | 7,023 | $5.1M |
| AMGNAMGEN INC | 11,971 | $4.2M |
| INDVIndivior Pharmaceuticals, Inc. | 134,108 | $4.1M |
| JNJJOHNSON & JOHNSON | 14,084 | $3.4M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 52,340 | $2.9M |
| AUPHAurinia Pharmaceuticals Inc. | 114,936 | $1.7M |
| TGTXTG THERAPEUTICS, INC. | 29,290 | $973K |
| PMPhilip Morris International Inc | 4,012 | $663K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,393 | $648K |
| ABTABBOTT LABORATORIES | 5,528 | $568K |
| GHGuardant Health Inc. | 5,254 | $485K |
| BMYBRISTOL MYERS SQUIBB CO | 7,900 | $479K |
| CLPTClearPoint Neuro Inc. | 50,000 | $455K |
| BCRXBIOCRYST PHARMACEUTICALS INC | 45,286 | $431K |
| BIIBBIOGEN INC. | 2,164 | $397K |
| ALHCAlignment Healthcare Inc. | 20,440 | $360K |
| IDXXIDEXX LABORATORIES INC /DE | 596 | $335K |
| ARQTArcutis Biotherapeutics, Inc. | 13,753 | $324K |
| MRKMerck & Co., Inc. | 2,600 | $313K |
| CPRXCATALYST PHARMACEUTICALS, INC. | 12,616 | $312K |
| CORCencora Inc. | 803 | $252K |
| GMOptec International, Inc. | 3,000 | $224K |
| PFEPFIZER INC | 7,840 | $220K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.